Skip to main content
SpringerLink
Log in

Rare Genitourinary Malignancies (Penile, Urethral, Renal Pelvis, and Ureteral Cancers)

  • Chapter
  • First Online:
Radiation Therapy for Genitourinary Malignancies

Part of the book series: Practical Guides in Radiation Oncology ((PGRO))

  • 645 Accesses

Abstract

Primary malignancies of the penis, urethra, and ureters are uncommonly referred for management with radiation therapy. The limited evidence for the efficacy of radiation for these rare malignancies is therefore not related to an intrinsic biological radioresistance, but a bias toward surgical management. Despite this pattern of care, primary radiation therapy can be used in the curative-intent setting, or as an adjuvant to surgery, both with or without chemotherapy depending on the clinical context. Given the rarity, it is critical persons diagnosed with penile, urethral, or ureteral cancers should be managed by multidisciplinary expert teams whenever practical.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hernandez BY, Barnholtz-Sloan J, German RR et al (2008) Burden of invasive squamous cell carcinoma of the penis in the United States, 1998–2003. Cancer 113(10):2883–2891

    Article  PubMed  Google Scholar 

  2. Pow-Sang MR, Ferreira U, Pow-Sang JM, Nardi AC, Destefano V (2010) Epidemiology and natural history of penile cancer. Urology 76(2):S2–S6

    Article  PubMed  Google Scholar 

  3. American Cancer Society (2020) Cancer facts & figures 2020. American Cancer Society, Atlanta, GA

    Google Scholar 

  4. American Cancer Society (2018) Risk factors for penile cancer. American Cancer Society, Atlanta, GA

    Google Scholar 

  5. Cubilla AL, Dillner J, Schellhammer PF et al (2014) Chapter 5: Tumors of the penis. In: Malignant epithelial tumors. IARC Press, Lyon, France, pp 281–290

    Google Scholar 

  6. Chaux A, Velazquez EF, Algaba F, Ayala G, Cubilla AL (2010) Developments in the pathology of penile squamous cell carcinomas. Urology 76(2 Suppl 1):S7–S14

    Article  PubMed  Google Scholar 

  7. Tward J (2018) The case for nonsurgical therapy of nonmetastatic penile cancer. Nat Rev Urol 15(9):574–584

    Article  PubMed  Google Scholar 

  8. Zequi Sde C, Guimaraes GC, da Fonseca FP et al (2012) Sex with animals (SWA): behavioral characteristics and possible association with penile cancer. A multicenter study. J Sex Med 9(7):1860–1867

    Article  PubMed  Google Scholar 

  9. Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ (2009) Penile cancer: epidemiology, pathogenesis and prevention. World J Urol 27(2):141–150

    Article  CAS  PubMed  Google Scholar 

  10. Cubilla AL, Velazquez EF, Amin MB et al (2018) The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations. Histopathology 72(6):893–904

    Article  PubMed  Google Scholar 

  11. AJCC cancer staging manual (2016) Springer Science+Business Media, New York

    Google Scholar 

  12. Lont AP, Besnard AP, Gallee MP, van Tinteren H, Horenblas S (2003) A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int 91(6):493–495

    Article  CAS  PubMed  Google Scholar 

  13. Gupta S, Rajesh A (2014) Magnetic resonance imaging of penile cancer. Magn Reson Imaging Clin N Am 22(2):191–199, vi

    Article  PubMed  Google Scholar 

  14. Kayes O, Minhas S, Allen C, Hare C, Freeman A, Ralph D (2007) The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol 51(5):1313–1318; discussion 1318–1319

    Article  PubMed  Google Scholar 

  15. Horenblas S, Kroger R, Gallee MP, Newling DW, van Tinteren H (1994) Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology 43(5):702–707

    Article  CAS  PubMed  Google Scholar 

  16. Penile Cancer, Version 1.2020. NCCN clinical practice guidelines in oncology (2020) J Natl Compr Canc Netw Web site. https://www.nccn.org/professionals/physician_gls/pdf/penile.pdf. Updated 14 Jan 2020. Accessed 10 June 2020

  17. Hakenberg OW, Minhas S, Necchi A, Protzel C, Watkin N, Robinson GAR (2020) EAU guidelines. Edn. presented at the EAU Annual Congress Amsterdam. EAU Guidelines Office. https://uroweb.org/guideline/penile-cancer/#10. Accessed 11 June 2020

  18. Ottenhof SR, Vegt E (2017) The role of PET/CT imaging in penile cancer. Transl Androl Urol 6(5):833–838

    Article  PubMed  PubMed Central  Google Scholar 

  19. NCCN clinical practice guidelines in oncology: penile cancer (2019) NCCN. https://www.nccn.org/professionals/physician_gls/pdf/penile.pdf. Accessed 4 Feb 2019

  20. Cubilla AL, Reuter V, Velazquez E, Piris A, Saito S, Young RH (2001) Histologic classification of penile carcinoma and its relation to outcome in 61 patients with primary resection. Int J Surg Pathol 9(2):111–120

    Article  CAS  PubMed  Google Scholar 

  21. Horenblas S (2001) Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: The role and technique of lymph node dissection. BJU Int 88(5):473–483

    Article  CAS  PubMed  Google Scholar 

  22. Slaton JW, Morgenstern N, Levy DA et al (2001) Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol 165(4):1138–1142

    Article  CAS  PubMed  Google Scholar 

  23. Solsona E, Algaba F, Horenblas S, Pizzocaro G, Windahl T (2004) EAU guidelines on penile cancer. Eur Urol 46(1):1–8

    Article  CAS  PubMed  Google Scholar 

  24. Solsona E, Iborra I, Rubio J, Casanova JL, Ricos JV, Calabuig C (2001) Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 165(5):1506–1509

    Article  CAS  PubMed  Google Scholar 

  25. Villavicencio H, Rubio-Briones J, Regalado R, Chechile G, Algaba F, Palou J (1997) Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol 32(4):442–447

    Article  CAS  PubMed  Google Scholar 

  26. Pizzocaro G, Piva L, Bandieramonte G, Tana S (1997) Up-to-date management of carcinoma of the penis. Eur Urol 32(1):5–15

    Article  CAS  PubMed  Google Scholar 

  27. Hadway P, Smith Y, Corbishley C, Heenan S, Watkin NA (2007) Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma. BJU Int 100(3):561–565

    Article  PubMed  Google Scholar 

  28. Kroon BK, Horenblas S, Estourgie SH, Lont AP, Valdes Olmos RA, Nieweg OE (2004) How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J Urol 171(6 Pt 1):2191–2194

    Article  CAS  PubMed  Google Scholar 

  29. Leijte JA, Kroon BK, Valdes Olmos RA, Nieweg OE, Horenblas S (2007) Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol 52(1):170–177

    Article  PubMed  Google Scholar 

  30. Zou ZJ, Liu ZH, Tang LY et al (2016) Radiocolloid-based dynamic sentinel lymph node biopsy in penile cancer with clinically negative inguinal lymph node: an updated systematic review and meta-analysis. Int Urol Nephrol 48(12):2001–2013

    Article  PubMed  Google Scholar 

  31. Zargar-Shoshtari K, Djajadiningrat R, Sharma P et al (2015) Establishing criteria for bilateral pelvic lymph node dissection in the management of penile cancer: lessons learned from an international multicenter collaboration. J Urol 194(3):696–701

    Article  PubMed  Google Scholar 

  32. EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam, 2020. ISBN 978-94-92671-07-3. https://uroweb.org/guideline/penile-cancer/#10

  33. Maddineni SB, Lau MM, Sangar VK (2009) Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer. BMC Urol 9:8

    Article  PubMed  PubMed Central  Google Scholar 

  34. Simpson WG, Klaassen Z, Jen RP, Hughes WM V, Neal DE Jr, Terris MK (2018) Analysis of suicide risk in patients with penile cancer and review of the literature. Clin Genitourin Cancer 16(2):e257–e261

    Article  PubMed  Google Scholar 

  35. Cordoba A, Escande A, Lopez S et al (2016) Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients). Radiat Oncol 11:96

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. de Crevoisier R, Slimane K, Sanfilippo N et al (2009) Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int J Radiat Oncol Biol Phys 74(4):1150–1156

    Article  PubMed  Google Scholar 

  37. Escande A, Haie-Meder C, Mazeron R et al (2017) Brachytherapy for conservative treatment of invasive penile carcinoma: prognostic factors and long-term analysis of outcome. Int J Radiat Oncol Biol Phys 99(3):563–570

    Article  PubMed  Google Scholar 

  38. Gotsadze D, Matveev B, Zak B, Mamaladze V (2000) Is conservative organ-sparing treatment of penile carcinoma justified? Eur Urol 38(3):306–312

    Article  CAS  PubMed  Google Scholar 

  39. Lont AP, Gallee MP, Meinhardt W, van Tinteren H, Horenblas S (2006) Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J Urol 176(2):575–580; discussion 580

    Article  CAS  PubMed  Google Scholar 

  40. Mistry T, Jones RW, Dannatt E, Prasad KK, Stockdale AD (2007) A 10-year retrospective audit of penile cancer management in the UK. BJU Int 100(6):1277–1281

    Article  PubMed  Google Scholar 

  41. McComas K, Agarwal N, Bowen G, Maughan BL, Tward JD (2020) Definitive ChemoRadiation for locally advanced, node positive, non-metastatic penile squamous cell carcinoma. Clin Genitourinary Cancer 18(5):e573–e584

    Article  Google Scholar 

  42. Bandieramonte G, Colecchia M, Mariani L et al (2008) Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur Urol 54(4):875–882

    Article  PubMed  Google Scholar 

  43. Bissada NK, Yakout HH, Fahmy WE et al (2003) Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma. J Urol 169(2):500–502

    Article  PubMed  Google Scholar 

  44. Brkovic D, Kalble T, Dorsam J et al (1997) Surgical treatment of invasive penile cancer—the Heidelberg experience from 1968 to 1994. Eur Urol 31(3):339–342

    Article  CAS  PubMed  Google Scholar 

  45. Brown MD, Zachary CB, Grekin RC, Swanson NA (1987) Penile tumors: their management by Mohs micrographic surgery. J Dermatol Surg Oncol 13(11):1163–1167

    Article  CAS  PubMed  Google Scholar 

  46. Burt LM, Shrieve DC, Tward JD (2014) Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 88(1):94–100

    Article  PubMed  Google Scholar 

  47. Crook J, Ma C, Grimard L (2009) Radiation therapy in the management of the primary penile tumor: an update. World J Urol 27(2):189–196

    Article  PubMed  Google Scholar 

  48. Edsmyr F, Andersson L, Esposti PL (1985) Combined bleomycin and radiation therapy in carcinoma of the penis. Cancer 56(6):1257–1263

    Article  CAS  PubMed  Google Scholar 

  49. Frimberger D, Hungerhuber E, Zaak D, Waidelich R, Hofstetter A, Schneede P (2002) Penile carcinoma. Is Nd:YAG laser therapy radical enough? J Urol 168(6):2418–2421; discussion 2421

    Article  CAS  PubMed  Google Scholar 

  50. Guimaraes GC, Cunha IW, Soares FA et al (2009) Penile squamous cell carcinoma clinicopathological features, nodal metastasis and outcome in 333 cases. J Urol 182(2):528–534; discussion 534

    Article  PubMed  Google Scholar 

  51. Kattan MW, Ficarra V, Artibani W et al (2006) Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis. J Urol 175(6):2103–2108; discussion 2108

    Article  PubMed  Google Scholar 

  52. Kiltie AE, Elwell C, Close HJ, Ash DV (2000) Iridium-192 implantation for node-negative carcinoma of the penis: the Cookridge Hospital experience. Clin Oncol 12(1):25–31

    CAS  Google Scholar 

  53. Korets R, Koppie TM, Snyder ME, Russo P (2007) Partial penectomy for patients with squamous cell carcinoma of the penis: the Memorial Sloan-Kettering experience. Ann Surg Oncol 14(12):3614–3619

    Article  PubMed  Google Scholar 

  54. Lopes A, Hidalgo GS, Kowalski LP, Torloni H, Rossi BM, Fonseca FP (1996) Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 156(5):1637–1642

    Article  CAS  PubMed  Google Scholar 

  55. Maiche AG (1989) Combined bleomycin and radiation treatment of penile carcinoma. Acta Oncol 28(4):548–549

    Article  CAS  PubMed  Google Scholar 

  56. Mazeron JJ, Langlois D, Lobo PA et al (1984) Interstitial radiation therapy for carcinoma of the penis using iridium 192 wires: the Henri Mondor experience (1970–1979). Int J Radiat Oncol Biol Phys 10(10):1891–1895

    Article  CAS  PubMed  Google Scholar 

  57. McLean M, Akl AM, Warde P, Bissett R, Panzarella T, Gospodarowicz M (1993) The results of primary radiation therapy in the management of squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 25(4):623–628

    Article  CAS  PubMed  Google Scholar 

  58. Meijer RP, Boon TA, van Venrooij GE, Wijburg CJ (2007) Long-term follow-up after laser therapy for penile carcinoma. Urology 69(4):759–762

    Article  PubMed  Google Scholar 

  59. Modig H, Duchek M, Sjodin JG (1993) Carcinoma of the penis. Treatment by surgery or combined bleomycin and radiation therapy. Acta Oncol 32(6):653–655

    Article  CAS  PubMed  Google Scholar 

  60. Neave F, Neal AJ, Hoskin PJ, Hope-Stone HF (1993) Carcinoma of the penis: a retrospective review of treatment with iridium mould and external beam irradiation. Clin Oncol 5(4):207–210

    Article  CAS  Google Scholar 

  61. Ornellas AA, Nobrega BL, Wei Kin Chin E, Wisnescky A, da Silva PC, de Santos Schwindt AB (2008) Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute. J Urol 180(4):1354–1359

    Article  PubMed  Google Scholar 

  62. Ozsahin M, Jichlinski P, Weber DC et al (2006) Treatment of penile carcinoma: to cut or not to cut? Int J Radiat Oncol Biol Phys 66(3):674–679

    Article  PubMed  Google Scholar 

  63. Pagliaro LC, Williams DL, Daliani D et al (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28(24):3851–3857

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Philippou P, Shabbir M, Malone P et al (2012) Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J Urol 188(3):803–808

    Article  PubMed  Google Scholar 

  65. Pietrzak P, Corbishley C, Watkin N (2004) Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int 94(9):1253–1257

    Article  PubMed  Google Scholar 

  66. Pond GR, Milowsky MI, Kolinsky MP et al (2014) Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma. Clin Genitourin Cancer 12(6):440–446

    Article  PubMed  Google Scholar 

  67. Rozan R, Albuisson E, Giraud B et al (1995) Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients). Radiother Oncol 36(2):83–93

    Article  CAS  PubMed  Google Scholar 

  68. Sarin R, Norman AR, Steel GG, Horwich A (1997) Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis. Int J Radiat Oncol Biol Phys 38(4):713–722

    Article  CAS  PubMed  Google Scholar 

  69. Schlenker B, Tilki D, Seitz M et al (2010) Organ-preserving neodymium-yttrium-aluminium-garnet laser therapy for penile carcinoma: a long-term follow-up. BJU Int 106(6):786–790

    Article  PubMed  Google Scholar 

  70. Shindel AW, Mann MW, Lev RY et al (2007) Mohs micrographic surgery for penile cancer: management and long-term follow-up. J Urol 178(5):1980–1985

    Article  PubMed  Google Scholar 

  71. Tang DH, Djajadiningrat R, Diorio G et al (2017) Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urol Oncol 35(10):605.e617–605.e623

    Article  Google Scholar 

  72. Tietjen DN, Malek RS (1998) Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology 52(4):559–565

    Article  CAS  PubMed  Google Scholar 

  73. Ubrig B, Waldner M, Fallahi M, Roth S (2001) Preputial flap for primary closure after excision of tumors on the glans penis. Urology 58(2):274–276

    Article  CAS  PubMed  Google Scholar 

  74. van Bezooijen BP, Horenblas S, Meinhardt W, Newling DW (2001) Laser therapy for carcinoma in situ of the penis. J Urol 166(5):1670–1671

    Article  PubMed  Google Scholar 

  75. Windahl T, Andersson SO (2003) Combined laser treatment for penile carcinoma: results after long-term followup. J Urol 169(6):2118–2121

    Article  PubMed  Google Scholar 

  76. Zouhair A, Coucke PA, Jeanneret W et al (2001) Radiation therapy alone or combined surgery and radiation therapy in squamous-cell carcinoma of the penis? Eur J Cancer 37(2):198–203

    Article  CAS  PubMed  Google Scholar 

  77. Franks KN, Kancherla K, Sethugavalar B, Whelan P, Eardley I, Kiltie AE (2011) Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals. J Urol 186(2):524–529

    Article  PubMed  Google Scholar 

  78. Myerson RJ, Garofalo MC, El Naqa I et al (2009) Elective clinical target volumes for conformal therapy in anorectal cancer: a Radiation Therapy Oncology Group Consensus Panel Contouring Atlas. Int J Radiat Oncol Biol Phys 74(3):824–830

    Article  PubMed  Google Scholar 

  79. Lisa Kachnic M (2005) A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for reduction of acute morbidity in carcinoma of the anal canal. RTOG. https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?action=openFile&FileID=4641. Accessed 15 June 2020

  80. Canter DJ, Nicholson S, Watkin N, Hall E, Pettaway C (2019) The International Penile Advanced Cancer Trial (InPACT): rationale and current status. Eur Urol Focus 5(5):706–709

    Article  PubMed  Google Scholar 

  81. Crook J (2010) Radiation therapy for cancer of the penis. Urol Clin 37(3):435–443

    Article  Google Scholar 

  82. Crook JM, Haie-Meder C, Demanes DJ, Mazeron JJ, Martinez AA, Rivard MJ (2013) American Brachytherapy Society-Groupe Europeen de Curietherapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy. Brachytherapy 12(3):191–198

    Article  PubMed  Google Scholar 

  83. Delannes M, Malavaud B, Douchez J, Bonnet J, Daly NJ (1992) Iridium-192 interstitial therapy for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 24(3):479–483

    Article  CAS  PubMed  Google Scholar 

  84. Swartz MA, Porter MP, Lin DW, Weiss NS (2006) Incidence of primary urethral carcinoma in the United States. Urology 68(6):1164–1168

    Article  PubMed  Google Scholar 

  85. Visser O, Adolfsson J, Rossi S et al (2012) Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer 48(4):456–464

    Article  CAS  PubMed  Google Scholar 

  86. Kaplan GW, Bulkey GJ, Grayhack JT (1967) Carcinoma of the male urethra. J Urol 98(3):365–371

    Article  CAS  PubMed  Google Scholar 

  87. Wiener JS, Liu ET, Walther PJ (1992) Oncogenic human papillomavirus type 16 is associated with squamous cell cancer of the male urethra. Cancer Res 52(18):5018–5023

    CAS  PubMed  Google Scholar 

  88. Wang EH, Yu JB (2016) Chemoradiation therapy for organ preservation in localized male urethral carcinoma. Oncology (Williston Park) 30(6):520–523

    CAS  Google Scholar 

  89. Gakis G, Witjes JA, Comperat E et al (2013) EAU guidelines on primary urethral carcinoma. Eur Urol 64(5):823–830

    Article  PubMed  Google Scholar 

  90. Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-Part B: Prostate and bladder tumours. Eur Urol 70(1):106–119

    Article  PubMed  Google Scholar 

  91. Carroll PR, Dixon CM (1992) Surgical anatomy of the male and female urethra. Urol Clin North Am 19(2):339–346

    Article  CAS  PubMed  Google Scholar 

  92. NCCN (2018) Urethral cancer. https://www.nccn.org/professionals/physician_gls/default.aspx#site

  93. Garden AS, Zagars GK, Delclos L (1993) Primary carcinoma of the female urethra. Results of radiation therapy. Cancer 71(10):3102–3108

    Article  CAS  PubMed  Google Scholar 

  94. Grigsby PW (1998) Carcinoma of the urethra in women. Int J Radiat Oncol Biol Phys 41(3):535–541

    Article  CAS  PubMed  Google Scholar 

  95. Milosevic MF, Warde PR, Banerjee D et al (2000) Urethral carcinoma in women: results of treatment with primary radiotherapy. Radiotherapy Oncol 56(1):29–35

    Article  CAS  Google Scholar 

  96. Weghaupt K, Gerstner GJ, Kucera H (1984) Radiation therapy for primary carcinoma of the female urethra: a survey over 25 years. Gynecol Oncol 17(1):58–63

    Article  CAS  PubMed  Google Scholar 

  97. Johnson DE, O’Connell JR (1983) Primary carcinoma of female urethra. Urology 21(1):42–45

    Article  CAS  PubMed  Google Scholar 

  98. Nicholson S, Tsang D, Summerton D (2008) Aggressive combined-modality therapy for squamous cell carcinoma of the female urethra. Nat Clin Pract Urol 5(10):574–577

    Article  CAS  PubMed  Google Scholar 

  99. Bagshaw HP, Williams NL, Huang YJ, Tward JD, Gaffney DK (2015) Palladium interstitial implant in combination with external beam radiotherapy and chemotherapy for the definitive treatment of a female urethral carcinoma. Gynecol Oncol Rep 13:40–43

    Article  PubMed  PubMed Central  Google Scholar 

  100. Kent M, Zinman L, Girshovich L, Sands J, Vanni A (2015) Combined chemoradiation as primary treatment for invasive male urethral cancer. J Urol 193(2):532–537

    Article  PubMed  Google Scholar 

  101. Cohen MS, Triaca V, Billmeyer B et al (2008) Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra. J Urol 179(2):536–541; discussion 541

    Article  CAS  PubMed  Google Scholar 

  102. Gheiler EL, Tefilli MV, Tiguert R, De Oliveira JG, Pontes JE, Wood DP (1998) Management of primary urethral cancer. Urology 52(3):487–493

    Article  CAS  PubMed  Google Scholar 

  103. Oberfield RA, Zinman LN, Leibenhaut M, Girshovich L, Silverman ML (1996) Management of invasive squamous cell carcinoma of the bulbomembranous male urethra with co-ordinated chemo-radiotherapy and genital preservation. Br J Urol 78(4):573–578

    Article  CAS  PubMed  Google Scholar 

  104. Son CH, Liauw SL, Hasan Y, Solanki AA (2018) Optimizing the role of surgery and radiation therapy in urethral cancer based on histology and disease extent. Int J Radiat Oncol Biol Phys 102(2):304–313

    Article  PubMed  Google Scholar 

  105. Kuettel MR, Parda DS, Harter KW, Rodgers JE, Lynch JH (1997) Treatment of female urethral carcinoma in medically inoperable patients using external beam irradiation and high dose rate intracavitary brachytherapy. J Urol 157(5):1669–1671

    Article  CAS  PubMed  Google Scholar 

  106. Magnuson WJ, Bradley K, Shaves M (2011) Successful management of female urethral carcinoma with radiation therapy and concurrent chemotherapy. Gynecol Oncol Case Rep 2(1):1–3

    PubMed  PubMed Central  Google Scholar 

  107. Sharma DN, Gandhi AK, Bhatla N, Kumar S, Rath GK (2016) High-dose-rate interstitial brachytherapy for female peri-urethral cancer. J Contemp Brachytherapy 8(1):41–47

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30

    Article  PubMed  Google Scholar 

  109. Holmang S, Lele SM, Johansson SL (2007) Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome. J Urol 178(1):51–56

    Article  PubMed  Google Scholar 

  110. Hafner C, Knuechel R, Zanardo L et al (2001) Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene 20(35):4910–4915

    Article  CAS  PubMed  Google Scholar 

  111. Box GN, Lehman DS, Landman J, Clayman RV (2008) Minimally invasive management of upper tract malignancies: renal cell and transitional cell carcinoma. Urol Clin North Am 35(3):365–383, vii

    Article  PubMed  Google Scholar 

  112. Lughezzani G, Sun M, Perrotte P et al (2010) Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A Population-based Study. Eur Urol 57(6):956–962

    Article  PubMed  Google Scholar 

  113. Hahn AW, Giri S, Pathak R, Bhatt VR, Martin MG (2016) Effect of adjuvant radiotherapy on survival in patients with locoregional urothelial malignancies of the upper urinary tract. Anticancer Res 36(8):4051–4055

    CAS  PubMed  Google Scholar 

  114. Cozad SC, Smalley SR, Austenfeld M, Noble M, Jennings S, Reymond R (1992) Adjuvant radiotherapy in high stage transitional cell carcinoma of the renal pelvis and ureter. Int J Radiat Oncol Biol Phys 24(4):743–745

    Article  CAS  PubMed  Google Scholar 

  115. Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W (2004) Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 172(4 Pt 1):1271–1275

    Article  CAS  PubMed  Google Scholar 

  116. Huang Y-C, Chang Y-H, Chiu K-H, Shindel AW, Lai C-H (2016) Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma. Sci Rep 6:38175

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Maehata Y, Kuriyama K, Aoki S, Araya M, Marino K, Onishi H (2015) Stereotactic body radiotherapy for localized ureter transitional cell carcinoma: three case reports. Case Rep Urol 2015:519897

    PubMed  PubMed Central  Google Scholar 

  118. Evans JD, Hansen CC, Tollefson MK, Hallemeier CL (2018) Stereotactic body radiation therapy for medically inoperable, clinically localized, urothelial carcinoma of the renal pelvis: a case report. Adv Radiat Oncol 3(1):57–61

    Article  PubMed  Google Scholar 

  119. Bentzen SM, Constine LS, Deasy JO et al (2010) Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 76(3 Suppl):S3–S9

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Walter Reed National Military Medical Center, Bethesda, MD, USA

    Anna M. Torgeson

  2. Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah School of Medicine, Salt Lake City, UT, USA

    Jonathan D. Tward

Authors
  1. Anna M. Torgeson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan D. Tward
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan D. Tward .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Loyola University Chicago, Maywood, IL, USA

    Abhishek A. Solanki

  2. Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA

    Ronald C. Chen

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Torgeson, A.M., Tward, J.D. (2021). Rare Genitourinary Malignancies (Penile, Urethral, Renal Pelvis, and Ureteral Cancers). In: Solanki, A.A., Chen, R.C. (eds) Radiation Therapy for Genitourinary Malignancies . Practical Guides in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-65137-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-65137-4_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-65136-7

  • Online ISBN: 978-3-030-65137-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation